China Neuropathic Pain Market Size & Outlook, 2025-2033


China Neuropathic Pain Market Insights

  • As per Reed Intelligence insights, the China Neuropathic Pain Market stood at USD 906.73 Million in 2024 and is anticipated to grow to USD 1391.19 Million by 2033.
  • The China market is expected to advance at a CAGR of 4.91% from 2026 through 2033.
  • In 2024, Peripheral Neuropathy accounted for the highest share of the By Type market size.
  • During the forecast period, Focal Neuropathy is set to register the highest growth, making it the most lucrative By Type segment.

Other Key Findings


  • China contributed 10.28% to the global Neuropathic Pain Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Neuropathic Pain Market.
  • In Asia Pacific, China is projected to capture the leading share of market size by 2033.
  • Among Asia Pacific markets, Singapore is expected to post the fastest growth, reaching USD 98.41 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 906.73 Million
Market Size In 2033 USD 1391.19 Million
Largest segment Peripheral Neuropathy
Units Revenue in USD Million
CAGR 4.91% (2025-2033)
Segmnetation Covered
By Type
  1. Peripheral Neuropathy
  2. Proximal Neuropathy
  3. Focal Neuropathy
  4. Autonomic Neuropathy
By Treatment
  1. Drug-Based
  2. Non-Drug Based
  3. By Route of Administration
  4. By Distribution Channel
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports